Department of Anesthesiology, Aarhus University Hospital, Aarhus, Denmark.
Crit Care Med. 2012 Nov;40(11):3013-25. doi: 10.1097/CCM.0b013e31825fd4ed.
Hypotensive resuscitation is gaining clinical acceptance in the treatment of hemorrhagic shock. Our aims were to investigate: 1) the effect of 7.5% NaCl with adenocaine (adenosine and lidocaine, AL) and AL with Mg (ALM) on fluid requirement to maintain a minimum mean arterial pressure of 50 mm Hg, and 2) the effect of a second bolus of 0.9% NaCl with AL during return of shed blood on cardiac and renal function in a porcine model of hemorrhagic shock.
Pigs were randomized to: Sham (n = 5), Sham + ALM/AL (n = 5), hemorrhage control (n = 11), or hemorrhage + ALM/AL (n = 9). Hemorrhage animals were bled to a mean arterial pressure of 35 mm Hg. After 90 mins, pigs were fluid resuscitated with Ringers acetate and 20 mL 7.5% NaCl with ALM to maintain a target mean arterial pressure of minimum 50 mm Hg. Shed blood and 0.9% NaCl with AL were infused 30 mins later. Hemorrhage control group was subjected to the same protocol but without ALM/AL. Hemodynamics, cardiodynamics (pressure-volume analysis), oxygen consumption, and kidney function were measured for 6 hrs.
University hospital laboratory.
Female farm-bred pigs.
Fluid volume infused during hypotensive resuscitation was 40% less in the 7.5% NaCl-/ALM-treated pigs than controls (25 vs. 41 mL/kg, p < .05). ALM was associated with a significant increase in dp/dtmax, end-systolic blood pressure, and systemic vascular resistance. Return of shed blood and 0.9% NaCl/AL reduced whole body oxygen consumption by 27% (p < .05), and significantly improved the end-systolic pressure-volume relationship and preload recruitable stroke work compared to controls. Glomerular filtration rate in the ALM/AL group returned to 83% of baseline compared to 54% in controls (p = .01).
Resuscitation with 7.5% NaCl ALM increases cardiac function and reduces fluid requirements during hypotensive resuscitation, whereas a second AL infusion during blood resuscitation transiently reduces whole body oxygen consumption and improves cardiac and renal function.
降压复苏在出血性休克治疗中逐渐得到临床认可。本研究旨在探讨:1)7.5%氯化钠与腺嘌呤(腺苷和利多卡因,AL)和 AL 与镁(ALM)对维持最小平均动脉压 50mmHg 所需的液体需求的影响,以及 2)在出血性休克猪模型中回输失血期间给予第二剂 0.9%氯化钠与 AL 对心脏和肾功能的影响。
猪被随机分为:假手术组(n=5)、假手术+ALM/AL 组(n=5)、出血控制组(n=11)或出血+ALM/AL 组(n=9)。出血动物的平均动脉压被降至 35mmHg。90 分钟后,使用醋酸林格氏液和 20mL7.5%ALM 氯化钠溶液进行液体复苏,以维持目标平均动脉压至少 50mmHg。30 分钟后输注回输失血和 0.9%氯化钠与 AL。出血控制组接受相同的方案,但不使用 ALM/AL。在 6 小时内测量血流动力学、心动力学(压力-容积分析)、耗氧量和肾功能。
大学医院实验室。
雌性农场饲养的猪。
在接受 7.5%氯化钠/ALM 治疗的猪中,低血压复苏期间输注的液体量比对照组少 40%(25 与 41ml/kg,p<.05)。ALM 与 dp/dtmax、收缩末期血压和全身血管阻力的显著增加相关。回输失血和 0.9%氯化钠/AL 使全身耗氧量降低 27%(p<.05),与对照组相比,显著改善收缩末期压力-容积关系和前负荷可复性工作。与对照组相比,ALM/AL 组的肾小球滤过率恢复到基线的 83%(p=0.01)。
复苏用 7.5%氯化钠 ALM 可增加心功能并减少低血压复苏期间的液体需求,而在血液复苏期间给予第二次 AL 输注会短暂降低全身耗氧量并改善心脏和肾功能。